Bilateral Adrenal Hyperplasia: Pathogenesis and Treatment

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Bilateral adrenal hyperplasia (BAH) is a rare cause of Cushing's syndrome (CS).
• Micronodular adrenal hyperplasia (PPNAD, iMAD) and macronodular adrenal hyperplasia (PBMAH) are distinct subtypes leading to CS.
• Diagnosis often relies on imaging, genetic testing, and screening for associated conditions like Carney complex.

Purpose of the Study:

• To review recent findings on the genetic and molecular causes of BAH.
• To discuss mechanisms affecting the PKA pathway and the role of the ARMC5 gene.
• To explore adrenal paracrine regulation and current treatment strategies, including unilateral adrenalectomy.

Main Methods:

• Literature review of genetic and molecular findings in BAH.
• Analysis of mechanisms altering the PKA pathway.
• Discussion of ARMC5 gene discovery and its implications.
• Review of adrenal paracrine regulation.
• Examination of current treatment data for unilateral adrenalectomy.

Main Results:

• Several genetic and molecular mechanisms contribute to BAH, often involving the PKA pathway.
• The ARMC5 gene has been recently identified as a significant factor in BAH.
• Adrenal paracrine regulation plays a role in the development of BAH.
• Unilateral adrenalectomy is emerging as a viable treatment option.

Conclusions:

• Understanding the genetic and molecular underpinnings of BAH is crucial for diagnosis and management.
• Targeting PKA pathway alterations and considering ARMC5 mutations are key areas of research.
• Adrenal paracrine signaling warrants further investigation.
• Unilateral adrenalectomy shows promise for treating BAH, offering a less invasive approach.